Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Metastatic Melanoma
Stopped early · Phase 1
Conditions studied: Melanoma (Skin)
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Clinical trial to study the effectiveness of chemotherapy plus bone marrow transplantation in treating patients with metastatic melanoma that has not responded to previous therapy.
Key facts
- Study ID
- NCT00003060
- Run by
- Louisiana State University Health Sciences Center Shreveport
- People needed
- 6
- Starts
- 1995-03-01
- Expected to finish
- 2001-02-22
- Last updated by the study team
- 2020-06-30
Who can join
Age: 16 and older, up to 44. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Louisiana State University School of Medicine — Shreveport, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.